✦ LIBER ✦

The Cost-Effectiveness of Plerixafor Plus G-CSF for Stem Cell Mobilization in Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (DLBCL)

✍ Scribed by S.M. Kymes; M. Gregory; D.L. Lambert; K.R. Carson; I. Pusic; J.F. DiPersio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peripheral blood stem cell mobilization

✍ Endo, T; Sato, N; Mogi, Y; Koizumi, K; Nishio, M; Fujimoto, K; Sakai, T; Kumano, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

A Phase II Study of Plerixafor (AMD3100)

✍ Amanda Cashen; Sandra Lopez; Feng Gao; Gary Calandra; Ron MacFarland; Karin Bade 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Comparative Cost-Effectiveness Of Plerix

✍ C.J. Campen; E.P. Armstrong; J.A. Christian; S. Hadeed; A.M. Yeager 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Health Economic Outcome Analysis Of Stem

✍ I. Pusic; S.M. Kymes; D.L. Lambert; M. Gregory; J.F. DiPersio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

PCN78 Cost-Effectiveness of Plerixafor P

✍ R.F. Duarte; J.A. Pérez-Simón; G. Martín; J. de la Rubia; P. Marín; M.A. Álvarez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

The role of cytotoxic therapy with hemat

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 48 KB